Hiroshi Maegawa

机构：Shiga University of Medical Science, Shiga University of Medical Science Hospital · ORCID：0000-0002-4611-8149

发表论文 552 篇 · 总被引 18088 次 · h-index 72

代表论文

• Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan (2022 · Diabetes Obesity and Metabolism · 被引 190)
• Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial (2023 · The Lancet Diabetes & Endocrinology · 被引 122)
• Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial (2023 · The Lancet Diabetes & Endocrinology · 被引 98)
• Ketone bodies: A double‐edged sword for mammalian life span (2023 · Aging Cell · 被引 39)
• Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70) (2022 · Journal of Diabetes Investigation · 被引 23)
• Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73) (2023 · Diabetes Obesity and Metabolism · 被引 20)